Oncimmune Reports Substantial Growth in their Interim Results & Alan Green on 3 Companies
Episode 2283, Feb 15, 2021, 01:05 PM
Oncimmune reports substantial revenue growth achieved with increased commercial activity across the business and Alan Green discusses Synairgen, Destiny Pharma and Mode Global Holdings
On the Vox Markets Podcast Today: 15th February 2021
Dr Adam M Hill, CEO of Oncimmune #ONC discusses the highlights from their interim results in which they report, substantial revenue growth with increased commercial activity across the business.
Alan Green, CEO of Brand Communications talks about: Synairgen #SNG Destiny Pharma & Mode Global Holdings #MODE
(Interview starts 12 minutes 40 seconds)
Plus the Top 5 Most Followed Companies & the Top 5 Most read RNS’s on Vox Markets in the last 24 hours.
Vox Markets is revolutionising the way companies engage with shareholders and the stock market at large. By aggregating IR and digital content onto one secure and compliant platform, Vox Markets has established itself as the go-to resource for the investment community.
#VoxMarkets #StockMarket #LivePrices #StockMarketNews #Money #Investing #Investments #Finance #Business #Podcast